AT1 4.35% 2.4¢ atomo diagnostics limited

Media Update, page-368

  1. 1,209 Posts.
    lightbulb Created with Sketch. 646

    A collection of news articles relating to AT1's biz channels

    Divoc (India Covid19 test distro)
    - their 2nd lab in Ghaziabad has now been NABL certified + listed on ICMR approved list for Covid19 tests
    https://www.icmr.gov.in/pdf/covid/labs/COVID_Testing_Labs_29042021.pdf(private lab #1129; previous one still certified also #146)


    - btw, according to other news articles, the company seems to now delivering diagnostics to 600 customers per day, 7 days/week (that's ~219k annually if they manage to keep this pace up! company still advises that its aiming to launch upto 100 labs across India, as quickly as possible)

    FebriDx (Lumos Diagnostics)
    -
    another positive real world study, sponsored by Ministry of Education, University and Research (Italy), done during the recent 2nd wave there
    https://www.sciencedirect.com/science/article/pii/S1201971221003775

    https://hotcopper.com.au/data/attachments/3138/3138568-fdc7649c60e2149b24849a6485a4a45b.jpg

    - What I found also interesting was that this study was not initiated by Lumos Diagnostics company...seems like FebriDx test rep is catching attention (since the UK study + hospital usage) in being useful for Covid19 infection filtering + would also be getting attention for its larger, longer term use for antiviral/bacterial differentiation too


    https://hotcopper.com.au/data/attachments/3138/3138571-d5112789547f8bb0bd1641e62e4e8401.jpg
    And general media articles on AT1-Viatris-Unitaid HIV deal (no new info in them)
    https://themarketherald.com.au/atomo-diagnostics-asxat1-and-viatris-to-support-hiv-self-test-supply-2021-04-29/


    https://www.360dx.com/point-care-testing/atomo-diagnostics-viatris-ink-deal-unitaid-expand-hiv-self-test-access#.YIurWbUzaM8

    https://www.thesentiment.com.au/how-three-companies-are-collaborating-to-tackle-an-epidemic/

    Btw, seems Unitaid's plan of 1m HIV tests will drive further takeup directly by those 135 distribution countries to procure "...21 million kits...between 2020 and 2023". I would think Viatris/AT1 + Abbott have the inside track in supplying this market from the Unitaid agreement.

    Hopefully AT1 can keep increasing HIV test production to maintain their market share alongside Abbott (who is a significantly larger, well established manufacturer)

 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.4¢
Change
0.001(4.35%)
Mkt cap ! $15.34M
Open High Low Value Volume
2.3¢ 2.5¢ 2.3¢ $4.929K 214.1K

Buyers (Bids)

No. Vol. Price($)
4 440421 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 97565 1
View Market Depth
Last trade - 15.42pm 31/07/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.